Type 2 Diabetes Treatment from the Highlands of Guatemala.

For travelers to Guatemala who have type 2 diabetes or those who follow our FB Group, we felt this would be of interest. We are not selling the products, we are only offering this information for those in need.

Type 2 Diabetes

For millions living with type 2 diabetes, the search for safer, more effective treatments is ongoing. While pharmaceutical companies continue to invest heavily in synthetic drugs, traditional medicine, especially plant-based healing practices, has quietly delivered promising results for generations.

In the highlands of Guatemala, a unique herbal formulation has been developed using local medicinal plants traditionally used to support blood sugar balance. This all-natural treatment is now being used by individuals with type 2 diabetes and is showing encouraging results: blood sugar levels stabilizing within normal ranges after just a few months of consistent use.

Type 2 Diabetes

Take, for example, Victoria Rodriguez, 35 years old. In 2011, she was diagnosed with early-stage diabetes after a check-up showed her blood sugar level at 150. For a year, she didn’t change her lifestyle or diet.

When she visited a naturopathic clinic, her glucose level had risen to 250. She began taking a natural tincture—Diabetes C—and after just three months, her blood sugar dropped to a healthy 95.

Victoria is just one of over 15 patients whose case studies have been documented as part of an observational study.

While this is not a formal clinical trial, the patient results suggest that this plant-based treatment deserves greater attention and further scientific investigation.

This natural treatment has been available for three years.

Type 2 Diabetes

Q150 per month (approximately USD 20) for individuals with type 2 diabetes who are traveling in Guatemala and looking for an alternative or complementary therapy. Each purchase includes clear instructions for use.

Please note: This is not a substitute for professional medical care. Always consult with your healthcare provider before beginning any new treatment.

To request more information or arrange to purchase a supply during your visit to Guatemala, contact: whereisguatemala@gmail.com

Type 2 Diabetes: A Costly American Epidemic

Type 2 diabetes affects over 38 million Americans, and the number continues to rise. This chronic condition, largely preventable through diet and lifestyle, occurs when the body becomes resistant to insulin or doesn’t produce enough of it.

The financial burden is staggering. In the U.S., the total cost of diagnosed diabetes was estimated at $413 billion in 2022, with Type 2 diabetes accounting for around 90–95% of cases. On average, a person with diabetes incurs more than twice the medical costs of someone without the disease.

Beyond the financial toll, diabetes leads to serious health complications, including heart disease, kidney failure, nerve damage, and vision loss. Prevention and early management are critical — not just for individual health, but for the long-term sustainability of the U.S. healthcare system.

Current Medications for Type 2 Diabetes: Costs & Effectiveness

1. Metformin

Class: Biguanide
Effectiveness: First-line therapy; lowers HbA1c by 1–1.5%.
Cost: Highly affordable; widely available as a generic.
Notes: Often used in combination with other medications for enhanced glycemic control.Wikipedia+1Wikipedia+1PubMed+1The Guardian+1

2. Sulfonylureas (e.g., Glibenclamide)

Effectiveness: Reduces HbA1c by 1–1.5%.
Cost: Low; generics are inexpensive.
Considerations: Risk of hypoglycemia and weight gain.The Guardian+1The Times+1

3. DPP-4 Inhibitors (e.g., Sitagliptin)

Effectiveness: Modest HbA1c reduction (0.5–0.8%).
Cost: Higher than metformin and sulfonylureas; varies by region.
Cost-Effectiveness: In Ecuador’s public health system, sitagliptin/metformin combination was found to be highly cost-effective compared to glibenclamide/metformin. NCBI+2CMAJ+2Wikipedia+2PubMed+2PubMed+2ScienceDirect+2

4. SGLT2 Inhibitors (e.g., Dapagliflozin, Canagliflozin)

Effectiveness: Lowers HbA1c by 0.5–1%; additional benefits include weight loss and cardiovascular protection.
Cost: Moderate to high; varies by country and insurance coverage.
Notes: Dapagliflozin has shown cardiovascular benefits and is effective in heart failure management. Verywell HealthWikipedia

5. GLP-1 Receptor Agonists (e.g., Semaglutide, Dulaglutide, Tirzepatide)

Effectiveness: Significant HbA1c reduction (up to 1.5%); promotes weight loss.
Cost:
- Semaglutide (Ozempic): Approximately $936/month in the U.S.
- Dulaglutide: Comparable pricing; varies by dosage and region.
- Tirzepatide (Mounjaro): Pricing varies; in the UK, costs around £122 ($153) per month through the NHS.
Cost-Effectiveness: Oral semaglutide has an incremental cost-effectiveness ratio (ICER) of approximately $36,939 per quality-adjusted life year (QALY) gained compared to empagliflozin, indicating potential cost-effectiveness. The Guardian+3Wikipedia+3Value in Health+3The Guardian+2Reuters+2The Times+2BioMed Central+2Value in Health+2NCBI+2

6. Insulin Therapy

Effectiveness: Highly effective in lowering HbA1c; essential for advanced cases.
Cost: Varies widely; newer analogs are more expensive.
Considerations: Risk of hypoglycemia; weight gain is common.

Summary of Costs (Approximate Monthly Prices in the U.S.)

Medication Class	Example Drug	Approximate Monthly Cost
Biguanides	Metformin	$4–$10
Sulfonylureas	Glibenclamide	$4–$10
DPP-4 Inhibitors	Sitagliptin	$400–$500
SGLT2 Inhibitors	Dapagliflozin	$500–$600
GLP-1 Receptor Agonists	Semaglutide	$900–$1,000
GLP-1 Receptor Agonists	Dulaglutide	$800–$900
GLP-1/GIP Receptor Agonist	Tirzepatide	$1,000–$1,200
Insulin (various types)	Insulin analogs	$300–$600